Evolent Health (EVH) Misses Q4 EPS by 9c, Misses on Revenue; Offers FY25 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts EVH Hot Sheet
Join SI Premium – FREE
Evolent Health (NYSE: EVH) reported Q4 EPS of ($0.02), $0.09 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $646.5 million versus the consensus estimate of $652.2 million.
GUIDANCE:
Evolent Health sees FY2025 revenue of $2.06-2.11 billion, versus the consensus of $2.42 billion.
For earnings history and earnings-related data on Evolent Health (EVH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Federal Realty Inv. Trust (FRT) Tops Q3 EPS by 3c ; Offers Guidance
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
